JOHANN O. SCHROEDER, M.D.; HANS H. EULER, M.D.; HELMUT LÖFFLER, M.D.
Two patients with severe systemic lupus erythematosus, who had not responded to conventional therapy, were treated with plasmapheresis and subsequent pulse cyclophosphamide. This approach uses the plasmapheresis-induced proliferation of pathogenic clones for partial clonal deletion by giving large doses of cytotoxic drugs during the assumed period of increased B-cell vulnerability. Both patients had a rapid and distinct improvement in clinical symptoms and laboratory parameters, including the control of a life-threatening case of lupus pneumonitis. Their conditions were stabilized by giving low-dose cyclophosphamide for the next 6 months. At 14-month follow-up, there were no clinical signs of relapse.
Learn more about subscription options.
Register Now for a free account.
SCHROEDER JO, EULER HH, LÖFFLER H. Synchronization of Plasmapheresis and Pulse Cyclophosphamide in Severe Systemic Lupus Erythematosus. Ann Intern Med. 1987;107:344–346. doi: 10.7326/0003-4819-107-2-344
Download citation file:
Published: Ann Intern Med. 1987;107(3):344-346.
Lupus Erythematosus, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only